The South African authorities said the detected cases and percentage of people testing positive are both increasing quickly, particularly in particularly in most populated province of Gauteng, North West and Limpopo regions of the country.
The fire started at around 5 pm from the microbiology department and thick plumes of smoke billowed from the building, sparking panic among patients, attendants and staff, and affecting emergency services.
Nobel laureate Peter Doherty says his 'big worry' is there could be refusals for other vaccines if doubts over its safety turn out to be true.
The study, which was conducted on more than 100 healthcare workers at three centres in India including Sir Ganga Ram Hospital, found that the B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-Delta infections (Ct value of 16.5 versus 19) but also generates greater transmission among the fully vaccinated HCWs.
Results from early-phase non-randomised vaccine trials in a total of 76 people show that two formulations of the vaccine have a good safety profile detected over 42 days, and induce antibody responses in all participants within 21 days.
The rapid molecular test is highly accurate and easy to use, making it a prime candidate for use in settings with limited testing capabilities, according to the researchers.
In a virtual conference from Moscow, Dmitriev said Sputnik V is not only 'one of the most effective' but also among the 'affordable' vaccines in the world.
'This virus may have more immune evasion capability and therefore, it may make you more sick.'
'We expect to get the approval in the next few weeks,' says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL).
According to government sources, the matter was discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22.
The reduced severity of the Omicron variant is good news for now, but it is the result of an 'evolutionary mistake' and does not indicate that the virus which causes COVID-19 is becoming less virulent, a leading Indian-origin scientist from the University of Cambridge warned on Thursday.
The AIIMS administration has initiated an internal inquiry to look into the cause of the fire and further strengthen preventive measure.
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.
China will carry out major scientific research to enhance its biosecurity science and technological capacity against future infectious diseases, state-run Global Times quoted Xiang as saying.
The reduced severity of Omicron is good news for now, but it is the result of an "evolutionary mistake" as Covid-19 is transmitting very efficiently and there is no reason for it to become milder, indicating that the next variant could be more virulent, a leading Indian-origin scientist from the University of Cambridge has warned.
'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'
Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.
The study revealed that the rise in temperatures leads to a decline in the transmission of the virus.
Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.
This year, India's Prime Minister Narendra Modi, Bollywood actor Ayushmann Khurrana, the 'dadi from Shaheen Bhagh' Bilkis, Alphabet and Google CEO Sundar Pichai and Professor Ravindra Gupta are among TIME's 100 most influential people of 2020.
A graduate in microbiology with a Master's in Business Management from the University of Edinburgh, Varalakshmi talks about her debut in Kannada cinema
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.
We asked you to share your 2 States stories and we've been inundated with your responses. Here is the latest one:
As we celebrate the spirit of childhood, here are some children who've made India proud.
While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.
Celebrity hairstylist Darshan Yewalekar has some advice for Indian men.
While some researchers are developing prototypes for ventilators to overcome their shortage, others have teamed up to develop testing kits.
In the fourth and final part of a series on Indian Americans who have won the George Marshall Scholarship in 2012, Arthur J Pais profiles microbiology student Paras Minhas, who wants to pursue a doctorate at the University College of London and treat mental disorders.
'Serial testing is much more valuable than a single test which reflects just a point in time.'
Indian American student Dr Sandeep Kishore, who was conferred with the 2012 Raymond W Sarber Awards, tells Aziz Haniffa what the award means to him and how he endeavours to bridge the gap between public sciences and public health.
Agri Biotech Foundation, with the mission of promoting Biotechnology, is offering PhD fellowships in agricultural biotechnology and socio-economic aspects of agricultural biotechnology.
'It's not about me - but about my jawans, my country,' says Lieutenant Bhavana Kasturi.
'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'
We invited readers to share their college recommendations for the Class of 2010. Share yours!
The president also said one of his daughters has been given a shot of the COVID-19 vaccination. "One of my daughters got vaccinated. In fact, she took part in an experiment. After the first vaccination, she had a [body] temperature of 38 degrees [Celcius, 100 degrees Fahrenheit], the next day slightly higher than 37 [degrees], that's all," he said.
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.
CREMA (Clinical Research Education and Management Academy) opens admissions for its one-year, part-time PG Diploma.
Dr Rajeshwari, head of the Microbiology department at the Narayan Hrudalaya in Bengaluru tells rediff.com about the effects of NDM-1 and also the measures needed to curb the spread of this enzyme.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances